Magnetic resonance imaging may be a promising way to detect lower levels of iron in the brain, helping determine which children have ADHD.
Magnetic resonance imaging may help detect lower brain iron levels among children with attention deficit hyperactivity disorder (ADHD), according to a study published in the journal Radiology.
Researchers from the Medical University of South Carolina and New York University School of Medicine performed a prospective study designed to assess brain iron levels among children with ADHD.
“Much debate and concern has emerged regarding the continual rise of ADHD diagnosis in the U.S. given that two-thirds of those diagnosed receive psychostimulant medications,” co-author Vitria Adisetiyo, PhD, said in a release. “We wanted to see if we could identify brain iron as a potential noninvasive biomarker for medication-naïve ADHD to prevent misdiagnosis.”
Twenty-two children and adolescents with ADHD, 12 of whom were medication-naïve, and 27 healthy children and adolescents were enrolled in the study. All subjects aged in range from 8 to 18. All underwent MR imaging and serum iron measures were also collected.
Results showed that the medication-naïve subjects with ADHD “had significantly lower striatal and thalamic MFC [magnetic field correlation] indexes of brain iron than did control subjects and psychostimulant-medicated subjects with ADHD.” Both the control group and the medicated ADHD group had comparable MFC indexes. Blood serum levels were similar among all subjects.
“Our research suggests that iron absorption into the brain may be abnormal in ADHD given that atypical brain iron levels are found even when blood iron levels in the body are normal,” Adisetiyo said.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.
Abbreviated MRI for Hepatocellular Carcinoma: What a New Meta-Analysis Reveals
January 6th 2025For hepatocellular carcinoma screening, a 19-study meta-analysis found the abbreviated MRI sequencing protocol of T2-weighted MRI, diffusion-weighted imaging (DWI) and hepatobiliary phase (HBP) imaging offered 88 percent sensitivity and 93 percent specificity.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.